Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology

Background: The effectiveness of corticosteroids in acute respiratory distress syndrome (ARDS) and COVID-19 still remains uncertain. Since ARDS is due to a hyperinflammatory response to a direct injury, we decided to perform a meta-analysis and an evaluation of robustness of randomised clinical tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas, Maria, Marra, Annachiara, Buonanno, Pasquale, Coviello, Antonio, Iacovazzo, Carmine, Servillo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624335/
https://www.ncbi.nlm.nih.gov/pubmed/34830569
http://dx.doi.org/10.3390/jcm10225287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624335/
https://www.ncbi.nlm.nih.gov/pubmed/34830569
http://dx.doi.org/10.3390/jcm10225287

Ejemplares similares